Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
Authors:
Open Access
- 10 January 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 1062650
Abstract
The mouse hippocampal neuronal cell line HT22 is frequently used as an in vitro model to investigate the role of hippocampal cholinergic neurons in cognitive functions. HT22 cells are derived from hippocampal neuronal HT4 cells. However, whether these cells exhibit the serotonergic neuronal phenotype observed in mature hippocampal neurons has not been determined yet. In this present study, we examined whether the differentiation of HT22 cells enhances the serotonergic neuronal phenotype, and if so, whether it can be used for antidepressant screening. Our results show that differentiation of HT22 cells promoted neurite outgrowth and upregulation of N-methyl-D-aspartate receptor and choline acetyltransferase, which is similar to that observed in primary cultured hippocampal neurons. Furthermore, proteins required for serotonergic neurotransmission, such as tryptophan hydroxylase 2, serotonin (5-hydroxytryptamine, 5-HT)1a receptor, and serotonin transporter (SERT), were significantly upregulated in differentiated HT22 cells. The transcription factor Pet-1 was upregulated during HT22 differentiation and was responsible for the regulation of the serotonergic neuronal phenotype. Differentiation also enhanced the functional serotonergic properties of HT22 cells, as evidenced by increase in intracellular 5-HT levels, serotonin transporter SERT glycosylation, and 5-HT reuptake activity. The sensitivity of 5-HT reuptake inhibition by venlafaxine in differentiated HT22 cells (IC50, 27.21 nM) was comparable to that in HEK293 cells overexpressing serotonin transporter SERT (IC50, 30.65 nM). These findings suggest that the differentiation of HT22 cells enhances their functional serotonergic properties, and these cells could be a potential in vitro system for assessing the efficacy of antidepressant 5-HT reuptake inhibitors.Keywords
Funding Information
- National Research Foundation of Korea
This publication has 34 references indexed in Scilit:
- 4-(4-(Dimethylamino)phenyl)-1-methylpyridinium (APP+) Is a Fluorescent Substrate for the Human Serotonin TransporterJournal of Biological Chemistry, 2012
- Serotonin Receptors in HippocampusThe Scientific World Journal, 2012
- A pathophysiological framework of hippocampal dysfunction in ageing and diseaseNature Reviews Neuroscience, 2011
- Discovery of Novel Selective Serotonin Reuptake Inhibitors through Development of a Protein-Based PharmacophoreJournal of Chemical Information and Modeling, 2011
- The hippocampus: hub of brain network communication for memoryTrends in Cognitive Sciences, 2011
- Pet-1 is required across different stages of life to regulate serotonergic functionNature Neuroscience, 2010
- Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatmentJournal of Psychiatry and Neuroscience, 2010
- HT22 hippocampal neuronal cell line possesses functional cholinergic propertiesLife Sciences, 2009
- Culturing hippocampal neuronsNature Protocols, 2006
- Induction and expression of long- and short-term neurosecretory potentiation in a neural cell lineNeuron, 1990